Literature DB >> 22342060

Analytical method development for synthesized conjugated metabolites of trans-resveratrol, and application to pharmacokinetic studies.

Otito F Iwuchukwu1, Satish Sharan, Daniel J Canney, Swati Nagar.   

Abstract

Trans-3,5,4'-trihydroxystilbene (trans-resveratrol, RES) exhibits very low bioavailability due to extensive conjugative metabolism. Whether RES metabolites exhibit pharmacologic activity is of great interest. The present study aimed at synthesis of monoconjugates of RES - the 3- and 4' monosulfates (R3S and R4'S), and the 3- and 4' monoglucuronides (R3G and R4'G). Synthesis, purification, and yield are described. Synthesized metabolites were utilized to develop a sensitive LC-MS(n) assay for direct quantitation of all analytes. The assay was validated for intra- and inter-day precision and accuracy. Synthesis of RES conjugates and development and validation of a sensitive bioanalytical assay were applied to pharmacokinetic evaluation of RES and its circulating monoconjugates in C57BL mice. The study is a first report of direct quantitation of RES monosulfates and monoglucuronides. These results will aid in characterizing the disposition of RES and its major or active metabolites in vivo. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22342060      PMCID: PMC3299880          DOI: 10.1016/j.jpba.2011.12.006

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  27 in total

1.  Bioanalytical method validation--a revisit with a decade of progress.

Authors:  V P Shah; K K Midha; J W Findlay; H M Hill; J D Hulse; I J McGilveray; G McKay; K J Miller; R N Patnaik; M L Powell; A Tonelli; C T Viswanathan; A Yacobi
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration.

Authors:  Xavier Vitrac; Alexis Desmoulière; Brigitte Brouillaud; Stéphanie Krisa; Gérard Deffieux; Nicole Barthe; Jean Rosenbaum; Jean Michel Mérillon
Journal:  Life Sci       Date:  2003-04-04       Impact factor: 5.037

3.  Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats.

Authors:  Elisabeth Wenzel; Tomislav Soldo; Helmut Erbersdobler; Veronika Somoza
Journal:  Mol Nutr Food Res       Date:  2005-05       Impact factor: 5.914

Review 4.  Physiological parameters in laboratory animals and humans.

Authors:  B Davies; T Morris
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

5.  Pharmacokinetic study of trans-resveratrol in adult pigs.

Authors:  María Azorín-Ortuño; María Josefa Yañéz-Gascón; Francisco J Pallarés; Fernando Vallejo; Mar Larrosa; María Teresa García-Conesa; Francisco Tomás-Barberán; Juan Carlos Espín
Journal:  J Agric Food Chem       Date:  2010-10-01       Impact factor: 5.279

6.  High absorption but very low bioavailability of oral resveratrol in humans.

Authors:  Thomas Walle; Faye Hsieh; Mark H DeLegge; John E Oatis; U Kristina Walle
Journal:  Drug Metab Dispos       Date:  2004-08-27       Impact factor: 3.922

7.  Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity.

Authors:  Lai-Xi Wang; Alonso Heredia; Haijing Song; Zhaojun Zhang; Biao Yu; Charles Davis; Robert Redfield
Journal:  J Pharm Sci       Date:  2004-10       Impact factor: 3.534

8.  Synthesis of phytoestrogenic isoflavonoid disulfates.

Authors:  Otto Soidinsalo; Kristiina Wähälä
Journal:  Steroids       Date:  2004-09       Impact factor: 2.668

9.  Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1980-04

10.  Human, rat, and mouse metabolism of resveratrol.

Authors:  Chongwoo Yu; Young Geun Shin; Anita Chow; Yongmei Li; Jerome W Kosmeder; Yong Sup Lee; Wendy H Hirschelman; John M Pezzuto; Rajendra G Mehta; Richard B van Breemen
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

View more
  6 in total

1.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

2.  In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide.

Authors:  Satish Sharan; Otito F Iwuchukwu; Daniel J Canney; Cheryl L Zimmerman; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2012-07-17       Impact factor: 3.922

3.  Pulmonary metabolism of resveratrol: in vitro and in vivo evidence.

Authors:  Satish Sharan; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2013-03-08       Impact factor: 3.922

4.  Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of α-synuclein via SIRT1-deacetylated LC3.

Authors:  Yan-Jie Guo; Su-Yan Dong; Xin-Xin Cui; Ya Feng; Te Liu; Ming Yin; Sheng-Han Kuo; Eng-King Tan; Wen-Juan Zhao; Yun-Cheng Wu
Journal:  Mol Nutr Food Res       Date:  2016-07-18       Impact factor: 5.914

Review 5.  An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol.

Authors:  Ashim Malhotra; Sundeep Bath; Fawzy Elbarbry
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

Review 6.  The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication.

Authors:  Mohamed Ouzzine; Sandrine Gulberti; Nick Ramalanjaona; Jacques Magdalou; Sylvie Fournel-Gigleux
Journal:  Front Cell Neurosci       Date:  2014-10-28       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.